Screener
CG Oncology CGON Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's total equity?
- CG Oncology (CGON) reported total equity of $1.03B in Q2 2026.
- How has CG Oncology's total equity changed year-over-year?
- CG Oncology's total equity increased by 53.5% year-over-year, from $670.36M to $1.03B.
- What is the long-term trend for CG Oncology's total equity?
- Over 3 years (2022 to 2025), CG Oncology's total equity has grown at a 113.2% compound annual growth rate (CAGR), from -$77.69M to $752.6M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about CG Oncology's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude